GlassScriptPhysician profile
Joshua Hendricks
NPI 1992298822
$5,329.36
in general payments reported to CMS, 2019-2025
15 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,205 · 2020: $1,356 · 2021: $718 · 2022: $165 · 2023: $524 · 2024: $42.57 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,998.14 | 2019-2025 | Citrefix, Prostep, Iconix |
| Integra Lifesciences Corporation | $1,194.20 | 2019-2021 | |
| Great Lakes Orthopedics | $725.85 | 2020 | |
| Medical Device Business Services, INC. | $421.99 | 2020-2021 | |
| Osteomed LLC | $213.02 | 2020-2022 | |
| Averitas Pharma INC. | $161.53 | 2023-2025 | Qutenza |
| Biotissue Holdings INC. | $155.44 | 2025 | |
| Saxum Surgical, INC. | $139.78 | 2023 | |
| Horizon Therapeutics Plc | $113.36 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $86.00 | 2021 | |
| Smith+Nephew, INC. | $29.16 | 2023 | Grafix |
| Depuy Synthes Sales INC. | $26.47 | 2024 | Orthovisc |
| Paragon 28, INC. | $25.31 | 2020 | |
| Organogenesis INC. | $23.01 | 2025 | Via Matrix |
| Avanos Medical | $16.10 | 2024 | On-Q* Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.